• Naftifine HCl: Mechanistic Depth and Experimental Decision-M

  2026-07-22

  Explore Naftifine HCl as an allylamine antifungal agent with unique mechanistic insight, including its role in squalene 2,3-epoxidase inhibition and advanced research applications. This article offers a deeper experimental perspective for selecting and optimizing topical antifungal treatments.

• Amyloid β-Peptide (1-42): Optimizing AD Research Workflows

  2026-07-21

  Amyloid β-Peptide (1-42) (Aβ42) is essential for modeling Alzheimer's disease, enabling high-impact neurotoxicity and microglial phagocytosis assays. This guide delivers actionable protocol refinements, troubleshooting intelligence, and insight into assay design, leveraging both landmark studies and APExBIO’s rigorously purified peptide.

• Astrocyte-Microglia Crosstalk Promotes CNS Repair via CSF1 a

  2026-07-21

  Cao et al. reveal a reciprocal signaling loop between astrocytes and microglia at the lesion border following spinal cord injury, mediated by CSF1 and IFN-β. This crosstalk is essential for microglial proliferation, astrogliosis, and neural repair, providing new insights into glial coordination in CNS regeneration.

• 5-Ethynyl-2'-deoxyuridine: Applied Cell Proliferation Insigh

  2026-07-20

  5-Ethynyl-2'-deoxyuridine (5-EdU) streamlines cell proliferation assays with high sensitivity and workflow efficiency, enabling rapid detection in developmental, regenerative, and tumor research. This guide provides practical protocol enhancements, troubleshooting solutions, and evidence-backed tips for maximizing 5-EdU’s advantages in modern laboratories.

• Heptamethine Cyanine Dye Targets Progesterone Receptors in B

  2026-07-20

  The referenced study introduces CA800-PR, a tumor-targeted heptamethine cyanine dye that selectively suppresses progesterone receptor activity in hormone receptor-positive breast cancer. This innovation demonstrates both imaging and therapeutic potential, marking a departure from conventional hormone therapies and providing new insights into Golgi apparatus disruption as an antitumor mechanism.

• Diphenyleneiodonium Chloride: Applied Redox and cAMP Assay G

  2026-07-19

  Diphenyleneiodonium chloride (DPI) stands out as a dual-action probe, enabling both precise inhibition of redox enzymes and targeted modulation of cAMP signaling pathways. This guide translates recent mechanistic insights and workflow advances into practical, reproducible protocols—empowering researchers to optimize oxidative stress and signal transduction assays with confidence.

• Protease Inhibitor Cocktail EDTA-Free: Precision in α-Synucl

  2026-07-18

  Explore how the Protease Inhibitor Cocktail EDTA-Free empowers advanced protein extraction and post-translational modification analysis, with a focus on α-synuclein pathology in neurodegenerative research. This in-depth review integrates mechanistic insights and practical protocol guidance.

• Resolving Pollen Interference in Hazardous Bioaerosol Detect

  2026-07-17

  This study introduces a machine learning-based approach to accurately classify hazardous substances in bioaerosols using excitation–emission matrix fluorescence spectroscopy, overcoming spectral interference from pollen. The methodology substantially improves detection reliability for public health applications and sets a foundation for advanced environmental biosurveillance.

• Targeting BCL-XL and MCL-1 in Glioblastoma: Enhanced Apoptot

  2026-07-17

  Koessinger et al. reveal that glioblastoma (GBM) cells exhibit increased expression of anti-apoptotic BCL-XL and MCL-1, which underlies their heightened sensitivity to BH3-mimetic inhibitors. These findings provide a mechanistic rationale for exploiting selective BCL-XL inhibition to overcome therapeutic resistance in GBM and related malignancies.

• Ciclesonide in Respiratory Research: Applied Protocols & Ins

  2026-07-16

  Ciclesonide’s prodrug design and robust activation in lung models make it a gold standard for asthma and allergic rhinitis research. This article delivers actionable workflows, troubleshooting strategies, and highlights how emerging ERAD-hijacking technologies can inform and optimize experimental setups.

• CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E

  2026-07-16

  This study uncovers CLCC1 as an essential host protein mediating the membrane fusion step of herpesvirus nuclear egress, using a genome-wide CRISPR screen. The findings advance understanding of nuclear envelope dynamics and have broad implications for viral replication and cellular membrane biology.

• SCH772984: ERK1/2 Inhibitor Protocols for MAPK/ERK Pathway I

  2026-07-15

  SCH772984 enables highly selective, nanomolar ERK1/2 inhibition for dissecting MAPK/ERK pathway roles in tumor radioresistance, proliferation, and survival. Its robust performance in BRAF, NRAS, and KRAS mutant models empowers translational oncology workflows and novel radiosensitization strategies.

• Pravastatin Sodium: Precision HMG-CoA Reductase Inhibitor Wo

  2026-07-15

  Explore how pravastatin sodium enables highly selective, reproducible cholesterol biosynthesis inhibition across diverse cell and animal models. This guide distills protocol enhancements, troubleshooting strategies, and cross-domain insights—empowering advanced cardiovascular and metabolic research.

• High-Throughput BBB Permeability Prediction Using LLC-PK1-MD

  2026-07-14

  This study introduces a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK and LLC-PK1-MDR1 cell lines, addressing key limitations in CNS drug screening by incorporating lysosomal trapping correction. The model demonstrates strong predictive power for in vivo brain distribution, offering a cost- and time-efficient platform for early CNS drug development.

• Inducing Right Ventricular Cardiomyocytes from Human PSCs

  2026-07-14

  Saito et al. introduce a robust protocol for specifically generating right ventricular-like cardiomyocytes from human pluripotent stem cells by modifying mesodermal differentiation cues. This work enables more precise disease modeling of right ventricular disorders and advances chamber-specific cardiac research.

413 records 8/28 page Previous Next First page 上5页 678910 下5页 Last page